Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Gamma Aryl Lactone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114605272A details a novel Nickel-catalyzed asymmetric hydrogenation route for (R)-Fluoxetine intermediates, offering significant cost reduction and high enantioselectivity for API manufacturing.